Pipeline — registered trials by phase
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Henry Schein is lead sponsor; 0 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- 8-K2026-10-08Current report (material event)
- 8-K2026-09-22Current report (material event)
- SCHEDULE 13G2026-08-06SCHEDULE 13G
- 10-Q2026-08-04Quarterly report
- 8-K2026-08-04Current report (material event)
- 8-K2026-07-30Current report (material event)
- 11-K2026-06-1811-K
- SD2026-05-29SD
- 8-K2026-05-22Current report (material event)
- DEFA14A2026-05-12DEFA14A
- 10-Q2026-05-05Quarterly report
- 8-K2026-05-05Current report (material event)
- SCHEDULE 13G2026-04-30SCHEDULE 13G
- ARS2026-04-08Annual report to holders
- DEFA14A2026-04-08DEFA14A
- DEF 14A2026-04-08Proxy statement
- SCHEDULE 13G/A2026-03-27SCHEDULE 13G/A
- SCHEDULE 13D/A2026-03-10SCHEDULE 13D/A
- 10-K2026-02-24Annual report
- 8-K2026-02-24Current report (material event)
- 8-K2026-01-12Current report (material event)
- 8-K2025-12-23Current report (material event)
- 8-K2025-12-23Current report (material event)
- SCHEDULE 13D/A2025-12-09SCHEDULE 13D/A
- 8-K2025-12-09Current report (material event)
- SCHEDULE 13G/A2025-12-03SCHEDULE 13G/A
- SCHEDULE 13D/A2025-11-06SCHEDULE 13D/A
- 10-Q2025-11-04Quarterly report
- 8-K2025-11-04Current report (material event)
- SCHEDULE 13G/A2025-10-31SCHEDULE 13G/A
- SCHEDULE 13G/A2025-10-30SCHEDULE 13G/A
- 8-K2025-09-09Current report (material event)
- SCHEDULE 13D/A2025-08-15SCHEDULE 13D/A
- SCHEDULE 13D/A2025-08-08SCHEDULE 13D/A
- 10-Q2025-08-05Quarterly report
- 8-K2025-08-05Current report (material event)
- 8-K2025-07-15Current report (material event)
- UPLOAD2025-07-08UPLOAD
- CORRESP2025-07-02CORRESP
- UPLOAD2025-06-24UPLOAD
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.